For a research institution to achieve its potential, its executive team must cultivate a spirit of inspiration and support. While Profil has grown quickly in recent years, we are proud of the stability and approachability of our management. Our executive team are involved in our day-to-day research into diabetes and obesity, remaining in direct contact with their teams of medical, scientific and informatics experts. Since their goal has always been scientific excellence rather than rapid growth, they also inspire their teams to strive for excellence in all Profil does.
Read about the entrepreneurial scientists who lead Profil.
Chief Executive Officer
Sascha Heckermann joined Profil in 2000 shortly after the inception of the company. From 2011 to 2016 he was CIO and since February 2016 he has been Chief Executive Officer of Profil Germany.
![]() ISO 13485:2016
|
![]() ISO 9001:2015
|
Kapitza, C. et al. 2021. A single-dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US- and European-approved versions of insulin aspart Mix 70/30 and SAR341402 rapid-acting solution in subjects with type 1 diabetes. Diabetes Obes Metab. 2021 Mar;23(3):674-681